Clinical strategies for the blockade of IL-18 in inflammatory bowel diseases.

Current drug targets

Volumn 14, Issue 12, 2013, Pages 1392-1399

  Kanai, Takanori ^a   Kamada, Nobuhiko ^b   Hisamatsu, Tadakazu ^b  

^a KEIO UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

CARRIER PROTEIN; INFLAMMASOME; INTERLEUKIN 18; INTERLEUKIN 8 RECEPTOR; NLRP3 PROTEIN, HUMAN;

ANIMAL; DISEASE MODEL; DRUG ANTAGONISM; GENETIC POLYMORPHISM; GENETICS; HUMAN; IMMUNOLOGY; INFLAMMATORY BOWEL DISEASE; MOLECULARLY TARGETED THERAPY; PATHOLOGY; PHYSIOLOGY; REVIEW;

ANIMALS; CARRIER PROTEINS; DISEASE MODELS, ANIMAL; HUMANS; INFLAMMASOMES; INFLAMMATORY BOWEL DISEASES; INTERLEUKIN-18; MOLECULAR TARGETED THERAPY; POLYMORPHISM, GENETIC; RECEPTORS, INTERLEUKIN-8;

MLCS; MLOWN;

EID: 84901382915     PISSN: None     EISSN: 18735592     Source Type: Journal    
DOI: 10.2174/13894501113149990006     Document Type: Review

References (0)